GZMB and inflammatory breast carcinoma: This study identifies GZMB and SPP1 as key immunosuppressive microenvironment-related prognostic biomarkers in IBC, establishes pDCs as central mediators of immunosuppressive niche remodeling, and offers novel therapeutic perspectives for immunotherapy in IBC.